Power

We're in the middle of the COVID-19 crisis. Big tech is already preparing for the next one.

A new working group from the Consumer Technology Association brings together Facebook, Microsoft and more to plan for future health crises.

A doctor holding a specimen bag

The Public Health Tech Initiative will develop recommendations for future health crises.

Photo: Mario Tama/Getty Images

As the U.S. continues its struggle to control the COVID-19 pandemic, a broad coalition of tech and health care organizations are banding together in hopes of helping the country prepare for the next one.

Yes, the next one.

On Monday, the Consumer Technology Association launched the Public Health Tech Initiative, a working group that includes prominent CTA members, including Microsoft, Facebook and Philips, as well as health care players like CVS Health, the American College of Cardiology, and Northwell Health, New York's largest health care provider. The goal of the group is to study how technology has been deployed — both successfully and unsuccessfully — during the current crisis and develop a set of recommendations for future public health emergencies. It plans to produce a white paper with its initial findings and then work with policymakers on implementing proposed changes.

"We heard about some of the issues from the pandemic. The lack of access to care. Lack of access to technology. … We were hearing that some of our public health authorities didn't have ready access to complete and accurate data," said Rene Quashie, vice president of digital health at CTA. "All of those things combined together just made us think that given who our members were, we could actually do something to address this in a meaningful way."

Dr. David Rhew, global chief medical officer of Microsoft, will co-chair the group, along with Dr. Alexander Garza, former chief medical officer at the Department of Homeland Security under President Obama and the current chief medical officer of SSM Health, a large health care system in the Midwest.

The group is, in many ways, trying to accomplish what the government has been so far unable to do: develop a unified strategy for deploying technology in a public health emergency. Giants like Apple and Google have dedicated resources to building contact-tracing apps, but the federal government has left it to the states to decide which tool to use, leading to paltry adoption rates across the country. Transferring patient data between health systems, meanwhile, remains clunky at best due to a patchwork system of medical record tools that don't always speak the same language.

"It really shows the fragmented nature of health care and public health within the U.S.," said Garza, who currently serves on St. Louis' pandemic task force. "Understanding how tech can help streamline data flows would be advantageous, not just for the government, but for a lot of different groups."

CTA's members already have plenty of examples of ways their technology has been used during the crisis. Microsoft, for one, has been working with governments around the world, providing cloud infrastructure and access to its AI tools as part of the search for a vaccine. Its health care chatbot became the basis of the Centers for Disease Control and Prevention's symptom tracker and has been used by first responders internationally for large-scale screening. Facebook has been feeding data about communities' mobility patterns to researchers working with local governments since the early days of the outbreak in the U.S. And Doctor on Demand, another member of the initiative, has been a key player in the exploding virtual health market.

But the group was deliberate in reaching beyond its own membership to include voices from the health care industry and elsewhere. "What was unique about this group we put together is it wasn't just tech companies," Rhew said. "We're talking about health care providers, payers, other individuals and organizations looking at this from all different angles. You need that 360-degree look at this problem."

CTA's task force certainly isn't the first of its kind. A similar effort focused on the current crisis and coordinated by the White House in March stumbled, with early members dropping out and a lack of agreement about what to focus on creating fissures within the group's ranks. Garza acknowledged that one of the group's hardest tasks will be determining how to properly scope its work for maximum impact. He's particularly interested in looking at issues like the rise of virtual care, the potential for wearable devices to be used to track patients, and the way information flows from the moment a patient gets tested to the moment their results get sent to health authorities. But he knows there are endless other issues to explore.

"We could write an encyclopedia about this. You have to pick the two or three things that are broad enough and important enough to work on," Garza said. "That can be challenging."

Protocol | Workplace

Productivity apps can’t stop making money

ClickUp had one of the biggest Series C funding rounds ever. Here's how it matches up to the other productivity unicorns.

ClickUp made $400 million in its series C funding round.

Photo: ClickUp

Productivity platform ClickUp announced a milestone today. The company raised $400 million, which is one of the biggest series C funding rounds in the workplace productivity market ever. The round, led by Andreessen Horowitz and Tiger Global, put the private company at a $4 billion valuation post-money.

In case it's not clear: This is a massive amount of money. It shows how hot the productivity space is right now, with some predicting the market size could reach almost $120 billion by 2028. In a world of hybrid workers, all-in-one tool platforms are all the rage among both startups and productivity stalwarts. Companies everywhere want to escape tool overwhelm, where work is spread across dozens of apps.

Keep Reading Show less
Lizzy Lawrence

Lizzy Lawrence ( @LizzyLaw_) is a reporter at Protocol, covering tools and productivity in the workplace. She's a recent graduate of the University of Michigan, where she studied sociology and international studies. She served as editor in chief of The Michigan Daily, her school's independent newspaper. She's based in D.C., and can be reached at llawrence@protocol.com.

If you've ever tried to pick up a new fitness routine like running, chances are you may have fallen into the "motivation vs. habit" trap once or twice. You go for a run when the sun is shining, only to quickly fall off the wagon when the weather turns sour.

Similarly, for many businesses, 2020 acted as the storm cloud that disrupted their plans for innovation. With leaders busy grappling with the pandemic, innovation frequently got pushed to the backburner. In fact, according to McKinsey, the majority of organizations shifted their focus mainly to maintaining business continuity throughout the pandemic.

Keep Reading Show less
Gaurav Kataria
Group Product Manager, Trello at Atlassian
The Supreme Court of the United States
Photo: Angel Xavier Viera-Vargas

If a company resolved a data breach in the past, does it need to disclose the potential negative fallout of that breach as a risk to investors later on? In a new petition asking the Supreme Court to take up the question, Alphabet is arguing emphatically: no. And it's using the ol' "the past is history, tomorrow's a mystery" defense.

Keep Reading Show less
Issie Lapowsky

Issie Lapowsky ( @issielapowsky) is Protocol's chief correspondent, covering the intersection of technology, politics, and national affairs. She also oversees Protocol's fellowship program. Previously, she was a senior writer at Wired, where she covered the 2016 election and the Facebook beat in its aftermath. Prior to that, Issie worked as a staff writer for Inc. magazine, writing about small business and entrepreneurship. She has also worked as an on-air contributor for CBS News and taught a graduate-level course at New York University's Center for Publishing on how tech giants have affected publishing.

Protocol | Workplace

Facebook’s hiring crisis: Engineers are turning down offers

"All of you are now starting to experience that major imbalance between supply and demand — and it doesn't feel good," a recruiting leader wrote in an internal memo.

Here are all the Facebook Papers stories
Image: Getty Images, Protocol

Facebook cannot find enough candidates to meet engineering demand, especially in the Bay Area, and has struggled and failed to meet early 2021 recruiting goals, according to a detailed internal memo outlining recruitment strategy and hiring pains.

The company also failed to meet hiring goals in 2019, which frustrated CEO Mark Zuckerberg, and it built an ad-hoc team of leaders to create an emergency plan to address the painful shortage, according to disclosures made to the Securities and Exchange Commission and provided to Congress in redacted form by Frances Haugen's legal counsel. A consortium of news organizations, including Protocol, has reviewed the redacted versions received by Congress.

Keep Reading Show less
Anna Kramer

Anna Kramer is a reporter at Protocol (Twitter: @ anna_c_kramer, email: akramer@protocol.com), where she writes about labor and workplace issues. Prior to joining the team, she covered tech and small business for the San Francisco Chronicle and privacy for Bloomberg Law. She is a recent graduate of Brown University, where she studied International Relations and Arabic and wrote her senior thesis about surveillance tools and technological development in the Middle East.

Theranos trial reveals DeVos family invested $100 million

The family committed "on the spot" to double its investment, an investment adviser said. Meanwhile, the jury lost another two members, with two alternates left.

Betsy DeVos' family invested $100 million in Theranos, an investment adviser said.

Photo: Alex Wong/Getty Images

Lisa Peterson, a wealth manager for the DeVos family, testified in Elizabeth Holmes's criminal fraud trial Tuesday, as prosecutors continued to highlight allegations about how the Theranos CEO courted investors in the once-high-flying blood-testing startup.

An email presented by the defense revealed that the family committed to doubling their investment in Theranos to $100 million "on the spot" during a 2014 visit to company headquarters.

Keep Reading Show less
Michelle Ma
Michelle Ma (@himichellema) is a reporter at Protocol, where she writes about management, leadership and workplace issues in tech. Previously, she was a news editor of live journalism and special coverage for The Wall Street Journal. Prior to that, she worked as a staff writer at Wirecutter. She can be reached at mma@protocol.com.
Latest Stories